News
Bristle Group, a Bentonville-based consumer product and technology company, announced Monday (July 14) new leadership as it looks to grow through investment and acquisition. Erik Hawkinson is CEO, and ...
Halozyme's ENHANZE technology drives strong near-term growth, but its key patent expires in 2027. Click here to find out why ...
International companies are increasingly inking licensing deals with China biotechs as concerns regarding drug pricing and ...
Denmark’s proposed deepfake law would rely on copyright protection to regulate likenesses, diverging from the U.S. criminal ban and the EU’s transparency-focused rules.
Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center in San Diego, California. With ...
Entrepreneur Anthem Pleasant blends floristry, patented tech, and solar EV innovation-anchored in 20+ years of ethical leadership and comm ...
The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.
Sun recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval ...
Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.
After resolving a patent dispute with Incyte, Sun Pharma has officially launched its JAK inhibitor Leqselvi in the U.S. | Sun ...
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
In a joint statement, the companies announced that both parties will withdraw the ongoing lawsuit and release each other from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results